JACKSON ANDREW C. (Chief Financial Officer) purchased 2.50K shares of CALIDI BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/25/2025ACC: 0001641172-25-025445
Officer· Chief Financial Officer
Since Oct 2023
+5K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$2.00
Trade value
$5K
% of position
New position
8/21/2025
0.00→2.50K
Total
Net shares
+2.50K
Net value
$5K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | P · Purchase | +2.50K | $2.00 | $5K | New position | 0.00 | 2.50K |
| Total | +2.50K | $5K | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common stock
2.50K shares
Shares
+2.50K
Strike price
2.00
Held after
2.50K
Exercisable
—
8/21/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common stock2.50K shares | 8/21/2025 | P · Purchase | +2.50K | 2.00 | — | 2.50K |